Fresenius medical care outlines 2025 operating income growth targets amid strategic transformations

2025-05-08 03:08:39 ET

More on Fresenius Medical Care AG, Fresenius Medical Care, etc.

• Fresenius Medical Care AG (FMS) Q1 2025 Earnings Conference Call Transcript
• Fresenius Medical Care: Why I'm Not (Yet) Biting Despite Turnaround Progress
• Fresenius: Holding On For Longer-Term Growth Driven By Demand In Kidney Care Segment
• Fresenius Medical Care Non-GAAP EPS of €0.84, revenue of €4.88B; reaffirms FY25 outlook
• Fresenius gets FDA approval for biosimilars of Amgen's bone-condition drugs

Read the full article on Seeking Alpha

For further details see: